Back to News
Market Impact: 0.3
Anthropic quietly sets up biology lab as it ramps AI drug program
Source: reuters.com
Artificial IntelligenceHealthcare & BiotechTechnology & Innovation
Anthropic has quietly established a laboratory focused on physical biology work, extending its AI ambitions into drug science. The move signals potential expansion beyond core AI models into biotech research, though no investment amount, partnerships, timeline, or commercial drug-development targets were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity
- Palantir reports booming U.S. commercial revenue growth, topping government for first time
- Anthropic releases amended IPO prospectus with third-quarter financials
- The AI boom is facing another supply crunch. This time it’s the amount of capital available to feed Silicon Valley’s endless need for cash
- Anthropic to Spend $895 Billion in the Years Ahead